Agios Pharmaceuticals, Inc.
AGIO
$33.18
$0.591.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 617.58M | 737.04M | 854.43M | 952.86M | 938.94M |
| Total Receivables | 24.22M | 16.13M | 10.78M | 5.03M | 4.99M |
| Inventory | 30.15M | 35.09M | 32.92M | 32.03M | 30.85M |
| Prepaid Expenses | 45.72M | 46.59M | 43.93M | 43.19M | 44.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 717.67M | 834.84M | 942.05M | 1.03B | 1.02B |
|
|
|||||
| Total Current Assets | 717.67M | 834.84M | 942.05M | 1.03B | 1.02B |
| Net Property, Plant & Equipment | 33.82M | 37.76M | 41.23M | 44.33M | 47.36M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.68M | 3.93M | 3.93M | 3.93M | 3.94M |
| Total Assets | 1.11B | 1.18B | 1.30B | 1.39B | 1.47B |
|
|
|||||
| Total Accounts Payable | 16.35M | 13.75M | 18.36M | 19.55M | 17.53M |
| Total Accrued Expenses | 34.65M | 26.29M | 45.46M | 37.22M | 35.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.23M | 18.81M | 18.39M | 17.99M | 17.59M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 70.22M | 58.85M | 82.21M | 74.76M | 70.41M |
|
|
|||||
| Total Current Liabilities | 70.22M | 58.85M | 82.21M | 74.76M | 70.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.95M | 16.94M | 21.82M | 26.53M | 31.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 240.00K | 90.00K | 90.00K | 90.00K | 101.00K |
| Total Liabilities | 82.40M | 75.88M | 104.11M | 101.38M | 101.68M |
|
|
|||||
| Common Stock & APIC | 2.59B | 2.57B | 2.56B | 2.54B | 2.52B |
| Retained Earnings | -761.52M | -660.82M | -561.71M | -453.67M | -350.23M |
| Treasury Stock & Other | -804.28M | -802.80M | -800.29M | -800.44M | -801.83M |
| Total Common Equity | 1.03B | 1.11B | 1.19B | 1.28B | 1.37B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.03B | 1.11B | 1.19B | 1.28B | 1.37B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.03B | 1.11B | 1.19B | 1.28B | 1.37B |
|
|
|||||